Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant changes (Expand Search)
significant non » significant gap (Expand Search), significant amount (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant changes (Expand Search)
significant non » significant gap (Expand Search), significant amount (Expand Search)
-
1761
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
1762
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
1763
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
1764
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
1765
-
1766
-
1767
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
1768
-
1769
Vitamin D3, but not the Cisplatin, could moderately reduce STZ-induced hyperglycemia in mice (a) Schematic representation of experimental protocol followed in the study: After accl...
Published 2025“…<p>The control non-diabetic group was administered with the vehicle used for dissolving the STZ, i.e., 100mM sodium citrate buffer, pH 4.5. …”
-
1770
-
1771
-
1772
-
1773
-
1774
-
1775
-
1776
-
1777
-
1778
-
1779
-
1780